Calpurbatug

N/A

Report date: 2024/10/09 20:00:32

Base Information

Drug NameCalpurbatug
Drug Alias NameTRL-1068
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionBacterial biofilms inhibitors
TargetsNot applicable
Therapy Area/IndicationsChronic rhinosinusitis with nasal polyps (CRSwNP)Prosthesis-Related Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrellis Bioscience LLC
China Registration ClassN/A

Develop Information

Active CompaniesTrellis Bioscience LLC
Inactive CompaniesN/A
Active IndicationsChronic rhinosinusitis with nasal polyps (CRSwNP)Prosthesis-Related Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A